Etana unveils biopharmaceutical factory in Indonesia

Therapeutics |  News | 0 Comment | 20 Oct, 2022

PT Etana Biotechnologies Indonesia (Etana) on 7 October, 2022, inaugurated a biopharmaceutical factory located...Read more

Korea's LG Chem to acquire AVEO Oncology for $566 M

Therapeutics |  News | 0 Comment | 20 Oct, 2022

South Korean chemical company LG Chem has announced a definitive agreement with AVEO Oncology in which LG Chem will...Read more

Singapore identifies new cell population in Alzheimer's disease

Therapeutics |  News | 0 Comment | 17 Oct, 2022

An immunity research study has found that the previously identified disease-associated microglia (DAM) population d...Read more

Australia provides $700k to fund new research on women’s fertility

Therapeutics |  News | 0 Comment | 17 Oct, 2022

The Australian government is providing almost $700,000 to fund new research investigating the impact of endometriosis on...Read more

Researchers in Korea study new set of biomarkers for diabetes, obesity treatment

Therapeutics |  News | 0 Comment | 14 Oct, 2022

According to International Diabetes Federation, approximately 537 million adults (20-79 years) are living with diabetes ...Read more

AdAlta and GPCR Therapeutics collaborate on novel cancer therapeutics

Therapeutics |  News | 0 Comment | 13 Oct, 2022

Australia based AdAlta Limited, the clinical stage drug discovery company and South Korea based GPCR Therapeutics Inc, a...Read more

Hong Kong identifies new therapeutic key to end cancer pain

Therapeutics |  News | 0 Comment | 13 Oct, 2022

A new study conducted by The Chinese University of Hong Kong’s (CUHK) Faculty of Medicine (CU Medicine) has discov...Read more

Singapore discovers non-invasive method to predict relapse of childhood cancers

Therapeutics |  News | 0 Comment | 11 Oct, 2022

The most common form of solid tumour affecting children is neuroblastoma. It is known to be the cause of a disproportion...Read more

Old drugs offer new ways of treating bowel cancer: NZ study

Therapeutics |  News | 0 Comment | 11 Oct, 2022

Old medicines, combined in new ways, are showing promise for treating bowel cancer, a group of University of Auckland re...Read more

Australia announces $5.4 M boost for brain cancer research

Therapeutics |  News | 0 Comment | 10 Oct, 2022

The Australian Government will invest more than $5.4 million in three groundbreaking brain cancer research projects.&nbs...Read more

Merck Singapore M Lab collaboration center leverages ChromConnect initiative

Therapeutics |  News | By Hithaishi C Bhaksar | 0 Comment | 08 Oct, 2022

On October 8, Singapore based Merck’s new M LabTM Collaboration Center brought Singapore's academic groups closer ...Read more

Education vital to help patients explore gene therapies for blindness: Australian study

Therapeutics |  News | 0 Comment | 07 Oct, 2022

Australians with inherited retinal disease (IRD) have a strong interest in undergoing gene therapy to prevent and treat ...Read more

Hong Kong develops novel RNA nanoparticle for atherosclerosis treatment

Therapeutics |  News | 0 Comment | 06 Oct, 2022

A team of researchers at The Chinese University of Hong Kong (CUHK) has developed a novel RNA nanoparticle to offer a po...Read more

Singapore pumps in SGD19.2 M for novel liver cancer treatment trial

Therapeutics |  News | 1 Comment | 06 Oct, 2022

A multi-national, investigator-initiated and industry-backed clinical trial has been launched to test the efficacy of a ...Read more

MRFF backs Monash health and medical research with $28M in funding

Therapeutics |  News | 0 Comment | 30 Sep, 2022

The Australian Government’s Medical Research Future Fund (MRFF) has invested $28 million in funding for Monash res...Read more

New Zealand opens doorways for better diabetic heart health

Therapeutics |  News | 0 Comment | 30 Sep, 2022

Dr June-Chiew Han and fellow researchers from Waipapa Taumata Rau University of Auckland, New Zealand are looking closel...Read more

First Southeast Asian study to advance pulmonary hypertension early detection

Therapeutics |  News | 0 Comment | 30 Sep, 2022

MiRXES Pte Ltd, a Singapore-headquartered biotechnology company, has collaborated with National University Hea...Read more

Biosyngen boosts cell therapy GMP capabilities in Singapore

Therapeutics |  News | 0 Comment | 28 Sep, 2022

Singapore-based startup Biosyngen has signed to set up a cell therapy GMP facility which will serve as a base to develop...Read more